Ronald N. Jones - Concepedia

Author

Ronald N. Jones

JMI Laboratories ORCID

Also Known As

Cyrus Hopkins, Helio Sader, Jones R, Jones, R N, Jones, Ronald, Karen Hadley, R JONES, R Jones, R N Jones, R. Jones

1.6K

Publications

71.2K

Citations

127

H-Index

212

Concepts

All Affiliations

JMI Laboratories University of Iowa Tufts University Universidade Federal de São Paulo

About

Ronald N. Jones is an author at JMI Laboratories specializing in medicine, clinical microbiology, and antimicrobial resistance.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	97	690	39.8K
2	Health Sciences	73	367	21.2K
3	Public Health	23	26	2.7K
4	Natural Sciences	12	13	702
5	Engineering	6	6	127

Ronald N. Jones

975

Publications

64K

Citations

122

H-Index

Page 1

	Year	Citations
Nosocomial Bloodstream Infections in United States Hospitals: A Three‐Year Analysis Michael B. Edmond, Stephanie E Wallace, Donna K. McClish, Clinical Infectious Diseases	1999	1.4K
Survey of Infections Due to<i>Staphylococcus</i>Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999 Daniel J. Diekema, Michael A. Pfaller, Franz‐Josef Schmitz, Clinical Infectious Diseases Western Pacific RegionStaphylococcus AureusUnited StatesDrug ResistanceHealthcare-associated Infection	2001	1.4K
Twenty Years of the SENTRY Antifungal Surveillance Program: Results for Candida Species From 1997–2016 Michael A. Pfaller, Daniel J. Diekema, John Turnidge, Open Forum Infectious Diseases	2019	776
10 x '20 Progress--Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America Helen W. Boucher, George H. Talbot, Daniel K. Benjamin, Clinical Infectious Diseases Systemic AntibioticsAntimicrobial ChemotherapyAntibiotic ResistanceUnited StatesInfectious Diseases Society	2013	692
The Microbiology of Bloodstream Infection: 20-Year Trends from the SENTRY Antimicrobial Surveillance Program Daniel J. Diekema, Po‐Ren Hsueh, Rodrigo E. Mendes, Antimicrobial Agents and Chemotherapy	2019	612
Bacterial Pathogens Isolated from Patients with Bloodstream Infection: Frequencies of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Michael A. Pfaller, Ronald N. Jones, Gary V. Doern, Antimicrobial Agents and Chemotherapy	1998	547
International Surveillance of Bloodstream Infections Due to <i>Candida</i> Species: Frequency of Occurrence and In Vitro Susceptibilities to Fluconazole, Ravuconazole, and Voriconazole of Isolates Collected from 1997 through 1999 in the SENTRY Antimicrobial Surveillance Program Michael A. Pfaller, Daniel J. Diekema, Ronald N. Jones, Journal of Clinical Microbiology	2001	523
Occurrence and antimicrobial resistance pattern comparisons among bloodstream infection isolates from the SENTRY Antimicrobial Surveillance Program (1997–2002) Douglas J. Biedenbach, Gary J. Moet, Ronald N. Jones Diagnostic Microbiology and Infectious Disease Bacterial ResistanceBloodstream Infection IsolatesAntimicrobial SusceptibilityHealth SciencesAntimicrobial Stewardship	2004	425
National Surveillance of Nosocomial Blood Stream Infection Due to Species of Candida Other than Candida albicans: Frequency of Occurrence and Antifungal Susceptibility in the SCOPE Program Michael A. Pfaller, Ronald N. Jones, S. A. Messer, Diagnostic Microbiology and Infectious Disease Antifungal AgentsScope ProgramCandida AlbicansClinical EpidemiologyHealthcare-associated Infection	1998	424
Antifungal Activities of Posaconazole, Ravuconazole, and Voriconazole Compared to Those of Itraconazole and Amphotericin B against 239 Clinical Isolates of <i>Aspergillus</i> spp. and Other Filamentous Fungi: Report from SENTRY Antimicrobial Surveillance Program, 2000 Michael A. Pfaller, S. A. Messer, R. J. Hollis, Antimicrobial Agents and Chemotherapy	2002	401

Page 1